---
figid: PMC8777795__metabolites-12-00031-g003
figtitle: 'Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease:
  Modulating Enteroendocrine System'
organisms:
- Glycine max
- Solanum lycopersicum
- Olea europaea
- Allium cepa
- Theobroma cacao
- Fagopyrum esculentum
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Escherichia coli
- gut metagenome
pmcid: PMC8777795
filename: metabolites-12-00031-g003.jpg
figlink: /pmc/articles/PMC8777795/figure/metabolites-12-00031-f003/
number: F3
caption: '(A) Flavonoids regulate IBD by the DPP-4/GLPs pathway: (1) protecting the
  intestinal barrier, (2) modulating Treg and intraepithelial lymphocytes (IELs) by
  managing their differentiation and functions and (3) adjusting the function of macrophages
  and dendritic cells. (B) Flavonoids regulate IBD by the ghrelin pathway: (1) increased
  food intake, (2) increase in growth hormone activity, (3) cardiovascular effects,
  (4) increased motility and (5) decreased local and systemic inflammation. (C) Flavonoids
  regulate IBD by the cholecystokinin (CCK) pathway: (1) decreasing the mucosal production
  of proinflammatory cytokines and protecting the intestinal barrier, (2) attenuating
  leukocyte migration and inhibiting dendritic cells (DCs) activation and (3) regulating
  T cells and B cells.'
papertitle: 'A Novel Pathway of Flavonoids Protecting against Inflammatory Bowel Disease:
  Modulating Enteroendocrine System.'
reftext: Mingrui Li, et al. Metabolites. 2022 Jan;12(1):31.
year: '2022'
doi: 10.3390/metabo12010031
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: MDPI
keywords: inflammatory bowel disease | flavonoids | GLP-1 | GLP-2 | DPP-4 inhibitors
  | ghrelin | cholecystokinin (CKK)
automl_pathway: 0.9587075
figid_alias: PMC8777795__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC8777795__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8777795__metabolites-12-00031-g003.html
  '@type': Dataset
  description: '(A) Flavonoids regulate IBD by the DPP-4/GLPs pathway: (1) protecting
    the intestinal barrier, (2) modulating Treg and intraepithelial lymphocytes (IELs)
    by managing their differentiation and functions and (3) adjusting the function
    of macrophages and dendritic cells. (B) Flavonoids regulate IBD by the ghrelin
    pathway: (1) increased food intake, (2) increase in growth hormone activity, (3)
    cardiovascular effects, (4) increased motility and (5) decreased local and systemic
    inflammation. (C) Flavonoids regulate IBD by the cholecystokinin (CCK) pathway:
    (1) decreasing the mucosal production of proinflammatory cytokines and protecting
    the intestinal barrier, (2) attenuating leukocyte migration and inhibiting dendritic
    cells (DCs) activation and (3) regulating T cells and B cells.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GCG
  - GLP1R
  - ZGLP1
  - TGFB1
  - TGFB2
  - TGFB3
  - WIPF2
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - DPP4
  - IGF1
  - IRF6
  - CCK
  - RIPK2
  - TRE-TTC3-1
  - TREH
  - NELFCD
  - Gcg
  - Tgfb1
  - Lce1e
  - Mcpt10
  - Dpp4
  - Igf1
  - Cck
  - Ltbp1
  - Lce1l
  - Wipf2
  - Gusb
  - Tnc
  - Glp2r
  - Loca1
  - Tlr4
  - Ripk2
  - Hand1
  - Nelfcd
  - Hand2
  - Mthfd1
---
